Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padmanee Sharma

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Cancer Immunology Research|September 13, 2023
Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023Padmanee Sharma, James P Allison
Science (New York, N.Y.)|January 7, 2012
Retrospective. Lloyd J. Old (1933-2011)Padmanee Sharma, James P Allison
Journal of Clinical Immunology|November 4, 2011
Current and emerging treatment options for castration-resistant prostate cancer: a focus on immunotherapyWinald R Gerritsen, Padmanee Sharma
Science (New York, N.Y.)|April 4, 2015
The future of immune checkpoint therapyPadmanee Sharma, James P Allison
Expert Review of Vaccines|December 22, 2009
Mechanisms of T-cell inhibition: implications for cancer immunotherapyElizabeth A Mittendorf, Padmanee Sharma
Science Translational Medicine|November 9, 2022
Immune checkpoint therapy: Forging aheadPadmanee Sharma, James P Allison
Nature Medicine|February 8, 2018
A potential biomarker for anti-PD-1 immunotherapySangeeta Goswami, Sreyashi Basu, Padmanee Sharma
Nature Reviews. Immunology|July 2, 2026
A guide to CAR T cell therapies: development, current status and future prospectsHind Rafei, Ranjan Upadhyay, Padmanee Sharma
Cancer Research|June 29, 2011
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapyTihui Fu, Qiuming He, Padmanee Sharma
Journal for Immunotherapy of Cancer|March 19, 2025
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasisShelley Herbrich, Mehdi Chaib, Padmanee Sharma
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Cancer Immunology Research|September 13, 2023
Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023Padmanee Sharma, James P Allison
Science (New York, N.Y.)|January 7, 2012
Retrospective. Lloyd J. Old (1933-2011)Padmanee Sharma, James P Allison
Journal of Clinical Immunology|November 4, 2011
Current and emerging treatment options for castration-resistant prostate cancer: a focus on immunotherapyWinald R Gerritsen, Padmanee Sharma
Science (New York, N.Y.)|April 4, 2015
The future of immune checkpoint therapyPadmanee Sharma, James P Allison
Expert Review of Vaccines|December 22, 2009
Mechanisms of T-cell inhibition: implications for cancer immunotherapyElizabeth A Mittendorf, Padmanee Sharma
Science Translational Medicine|November 9, 2022
Immune checkpoint therapy: Forging aheadPadmanee Sharma, James P Allison
Nature Medicine|February 8, 2018
A potential biomarker for anti-PD-1 immunotherapySangeeta Goswami, Sreyashi Basu, Padmanee Sharma
Nature Reviews. Immunology|July 2, 2026
A guide to CAR T cell therapies: development, current status and future prospectsHind Rafei, Ranjan Upadhyay, Padmanee Sharma
Cancer Research|June 29, 2011
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapyTihui Fu, Qiuming He, Padmanee Sharma
Journal for Immunotherapy of Cancer|March 19, 2025
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasisShelley Herbrich, Mehdi Chaib, Padmanee Sharma
Pageof 22